Company intelligence / Profile preview
PhytoHealth Corporation
Taipei, Taiwanphytohealth.com.tw ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
The company has multiple products in various stages including approved drugs (PG2 for Fatigue, Phencynonate for Motion Sickness), Phase 3 (JKB-122 for Nonalcoholic Steatohepatitis), Phase 2 (PHN013 for Purpura), and Clinical stage (PHN014 for Acute Ischemic Stroke)
- Therapeutic areas
- GastroenterologyCardiovascularHematologyOtherOncologyNeurology
- Modalities
- Small molecule drugsHerbal medicineChemical drugsBotanical-based pharmaceuticals
- Industry
- Biotech
02
Drug pipeline
18 assets17 more assets in the full pipeline.
Beyond the preview
Go deeper on PhytoHealth Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PhytoHealth Corporation.